T. Rowe Price Investment Management, Inc. Eli Lilly & CO Call Options Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LLY
# of Institutions
3,932Shares Held
762MCall Options Held
6.38MPut Options Held
7.96M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$80.6 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.9MShares$61.4 Billion1.31% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$54.8 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$42.7 Billion29.2% of portfolio
-
State Street Corp Boston, MA33.9MShares$28.2 Billion1.36% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $790B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...